Rating Change
Bernstein analysts reiterated a Outperform rating on Cigna Corporation (NYSE:CI) on July 09, 2026.
Rating Change Bernstein analysts reiterated a Outperform rating on Cigna Corporation (NYSE:CI) on July 09, 2026. Market Context Cigna Corporation operates in the Healthcare…

Bernstein analysts reiterated a Outperform rating on Cigna Corporation (NYSE:CI) on July 09, 2026.
Cigna Corporation operates in the Healthcare sector. The stock currently trades at $291.66 with a market capitalization of $72.7B. The stock has gained 13.0% over the past 52 weeks.
Analyst coverage from Bernstein provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Cigna Corporation.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Among the 10 most recent ratings: 8 Buy, 2 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jul 09, 2026 | Bernstein | Outperform | N/A |
| Jun 08, 2026 | Mizuho | Outperform | N/A |
| May 26, 2026 | Barclays | Equal-Weight | N/A |
| May 22, 2026 | UBS | Buy | N/A |
| May 20, 2026 | Deutsche Bank | Hold | N/A |
Related Tools: Analyst Ratings Dashboard | View CI Stock Page
A Outperform rating from Bernstein reflects the analyst's outlook on Cigna Corporation (NYSE:CI). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the CI forecast page.
Current market data
NYSE · CI
$278.88
Up: +$1.21 · +0.44%
Live quote updated
Keep reading